✦ LIBER ✦

Hepatitis B: Modern End Points of Treatment and the Specter of Viral Resistance

✍ Scribed by Lee, Maximilian; Keeffe, Emmet B.

Book ID: 119952911
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 211 KB
Volume: 40
Category: Article
ISSN: 0889-8553
DOI: 10.1016/j.gtc.2011.06.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Surrogate end-points for treatment trial

Surrogate end-points for treatment trials of hepatitis B virus

✍ P. D. Griffiths 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB

Treatment of chronic hepatitis B and the

Treatment of chronic hepatitis B and the implications of viral resistance to therapy

✍ Mauss, Stefan ;Wedemeyer, Heiner 📂 Article 📅 2008 🏛 Expert Reviews 🌐 English ⚖ 496 KB

Treatment of pediatric chronic viral hep

Treatment of pediatric chronic viral hepatitis B and C

✍ Hierro, L.; Fischler, B. 📂 Article 📅 2014 🏛 Elsevier 🌐 French ⚖ 409 KB

HBeAg seroconversion as an important end

HBeAg seroconversion as an important end point in the treatment of chronic hepatitis B

✍ Yun-Fan Liaw 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 338 KB

Viral features of lamivudine resistant h

Viral features of lamivudine resistant hepatitis B genotypes A and D

✍ Bernhard Zöllner; Jörg Petersen; Elisabeth Puchhammer-Stöckl; Josef Kletzmayr; M 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 196 KB

Viral differences among lamivudine resistant hepatitis B (HBV) genotypes have not been yet investigated. Therefore, we analyzed the characteristics of these viral strains in vivo. Fortyone patients carrying lamivudine resistant HBV were enrolled. Twenty-six patients (63%) carried resistant HBV genot

New approaches to the treatment of chron

New approaches to the treatment of chronic viral hepatitis B and C

✍ Fredric Regenstein 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 669 KB